Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Caspase 10 anticorps

L’anticorps Souris Monoclonal anti-Caspase 10 a été validé pour WB. Il convient pour détecter Caspase 10 dans des échantillons de Humain.
N° du produit ABIN5541750

Aperçu rapide pour Caspase 10 anticorps (ABIN5541750)

Antigène

Voir toutes Caspase 10 (CASP10) Anticorps
Caspase 10 (CASP10) (Caspase 10, Apoptosis-Related Cysteine Peptidase (CASP10))

Reactivité

  • 78
  • 15
  • 5
Humain

Hôte

  • 70
  • 4
  • 2
  • 1
  • 1
Souris

Clonalité

  • 65
  • 13
Monoclonal

Conjugué

  • 43
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Caspase 10 est non-conjugé

Application

  • 40
  • 25
  • 18
  • 15
  • 13
  • 13
  • 13
  • 9
  • 9
  • 3
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB)

Clone

4C1
  • Specificité

    This antibody detects specifically 57 and 58 kDa of human caspase-10, 43 kDa and 30 kDa of human active caspase-10 on Western blotting (Ref.8). This antibody reacts with isoforms caspase-10/a, 10/b and 10/d (Ref.17).

    Réactivité croisée (Details)

    Does not react with Mouse (WR19L).

    Purification

    Protein A agarose

    Immunogène

    Recombinant full-length of human FLICE2

    Isotype

    IgG1
  • Indications d'application

    Western blot: 1 μg/mL for chemiluminescence detection system. For details see protocol below.

    Protocole

    SDS-PAGE & Western Blotting 1) Wash cells (approximately 1 x 10 7 cells) 3 times with PBS and resuspend them in 10 volume of cold Lysis buffer (50 mM Tris-HCl, pH 7.2, 250 mM NaCl, 0.1 % NP-40, 2 mM EDTA, 10 % glycerol) containing protease inhibitors at appropriate concentrations. Incubate it at 4 o C with rotating for 30 minutes thereafter, briefly sonicate the mixture (up to 10 seconds). 2) Centrifuge the tube at 12,000 x g for 10 minutes at 4 o C and transfer the supernatant to another tube. Measure the protein concentration of the supernatant and add the cold Lysis buffer to make 8 mg/mL solution. 3) Mix the sample with equal volume of Laemmli's sample buffer. 4) Boil the samples for 3 minutes and centrifuge. Load 10 μ L of sample per lane on a 1-mm-thick SDS-polyacrylamide gel and carry out electrophoresis. 5) Blot the protein to a polyvinylidene difluoride (PVDF) membrane at 1 mA/cm 2 for 1 hour in a semi-dry transfer system (Transfer Buffer: 25 mM Tris, 190 mM glycine, 20 % MeOH). See the manufactur er's manual for precise transfer procedure. 6) To reduce nonspecific binding, soak the membrane in 10 % skimmed milk (in PBS, pH 7.2) for 1 hour at room temperature, or overnight at 4 o C. 7) Incubate the membrane with primary antibody diluted with PBS, pH 7.2 containing 1 % skimmed milk as suggested in the APPLICATIONS for 1 hour at room temperature. (The concentration of antibody will depend on the conditions.) 8) Wash the membrane with PBS-T [0.05 % Tween-20 in PBS] (5 minutes x 3 times). 9) Incubate the membrane with the 1:5,000 HRP-conjugated anti-mouse IgG diluted with 5 % skimmed milk (in PBS, pH 7.2) for 1 hour at room temperature. 10) Wash the membrane with PBS-T (10 minutes x 3 times). 11) Drain excess buffer on the membrane, and incubate membrane with an appropriate chemiluminescence reagent for 1 minute. 12) Remove extra reagent from the membrane by dabbing with a paper towel, and seal it in plastic wrap. 13) Expose the membrane onto an X-ray film in a dark room for 2 minutes. 14) Develop the film under usual settings. The conditions for exposure and development may vary. (Positive controls for Western blotting Jurkat, Raji, U937, HeLa, HEp-G2) Apoptosis induction 1) 2 x 10 4 cells/50 μ L of Jurkat cells or WR19L12a cells (human Fas transfectant) was cultured in 96-well microplate at 37 o C in 5 % CO 2 incubator with RPMI 1640 containing 10 % fetal calf serum. 2) Add 50 μ L of 200 ng/mL anti-human Fas monoclonal antibody diluted with RPMI 1640 containing 10 % fetal calf serum. 3) Cultured for appropriate times at 37 o C in 5 % CO 2 incubator with RPMI 1640 containing 10 % fetal calf serum.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS containing 50 % glycerol, pH 7.2. No preservative is contained.

    Agent conservateur

    Azide free

    Stock

    -20 °C

    Stockage commentaire

    Upon receipt, store undiluted (in aliquots) at -20°C. Avoid repeated freezing and thawing. Shelf life: One year from despatch.
  • Antigène

    Caspase 10 (CASP10) (Caspase 10, Apoptosis-Related Cysteine Peptidase (CASP10))

    Autre désignation

    caspase-10

    Sujet

    Apoptosis is a major form of cell death characterized by several morphological features that include chromatin condensation and fragmentation, cell membrane blebbing, and formation of apoptotic bodies. These morphological changes occur via signaling pathway that leads to the recruitment and activation of caspases, a family of cysteine-containing , aspartate-specific proteases. Caspases exist as inactive proenzymes in cells and are activated through their processing into two subunits in response to apoptotic stimulation. Activated caspases cleave a variety of important cellular proteins, other caspases, and Bcl-2 family members, leading to a commitment to cell death. Ca spase-10 (also known as Mch4, FLICE2 and ICE-LAP4) is a ~58 kDa protein. This caspase acts upstream of the apoptosis induced cascade. Once this caspase is activated by certain apoptotic stimuli, this protein may be responsible for the activation of the other caspases such as caspase-3, -4, -7, -8, and -9. This antibody was made against human-originated immunogen, and detects human caspase-10 specifically.

    UniProt

    Q92851

    Pathways

    Apoptose, Caspase Cascade in Apoptosis
Vous êtes ici:
Chat with us!